Colgate-Palmolive Company’s Stock Price Drops to $90.96, Witnessing a 3.14% Dip: Time to Sell or Buy?

Colgate-Palmolive Company (CL)

90.96 USD -2.95 (-3.14%) Volume: 7.17M

Colgate-Palmolive Company’s stock price stands at 90.96 USD, witnessing a drop of -3.14% in the current trading session with a trading volume of 7.17M, yet maintaining a marginal year-to-date growth of +0.05%, highlighting its resilience in the stock market.

Latest developments on Colgate-Palmolive Company

Colgate-Palmolive Co’s stock price movements today can be traced back to key events such as their webcast of the 2025 Annual Meeting of Stockholders where analysts increased their forecasts following upbeat results. Despite facing tariff challenges, Colgate-Palmolive managed to navigate through them in their Q1 2025 Earnings Call. However, economic uncertainty led to a cut in outlook, spooking shoppers and causing a drop in sales. Despite this, the company raised its annual sales forecast, showing resilience in the face of challenges. Analysts remain optimistic, with Citi boosting Colgate-Palmolive’s price target to $108, indicating confidence in the company’s long-term prospects.

Colgate-Palmolive Company on Smartkarma

Analysts at Baptista Research on Smartkarma have published insightful reports on Colgate Palmolive Co, examining the company’s promotional strategies, market adaptation, and financial performance. In one report titled “Colgate-Palmolive: Will Its Promotional Strategies & Market Adaptation Be A Potential Game Changer?”, the analysts highlight the company’s strong financial performance in 2024, with net sales reaching $20 billion ahead of its strategic plan. Colgate-Palmolive reported high single-digit organic growth, driven by balanced pricing and volume growth across all divisions and categories. The report leans bullish on the company’s prospects.

Another report by Baptista Research, “Colgate-Palmolive Company: Will Its Innovation & Market Adaptation in Latin America Bring A Shift In The Competitive Dynamics? – Major Drivers”, discusses the company’s third-quarter earnings report. The report acknowledges both promising aspects and areas of concern, noting the consistent top and bottom-line growth achieved by Colgate-Palmolive. The quarter saw strong volume-led organic sales expansion, with significant contributions from both developed and emerging markets. Overall, the report leans bullish on the company’s innovation and market adaptation strategies in Latin America.

A look at Colgate-Palmolive Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Colgate Palmolive Co has a mixed outlook based on the Smartkarma Smart Scores. The company scores well in Momentum, indicating strong growth potential in the future. With a high score in Growth, Colgate Palmolive Co is expected to continue expanding its market presence. However, the company falls short in Value, suggesting that its stock may not be undervalued. Overall, Colgate Palmolive Co shows promise for growth and resilience in the consumer products industry.

Colgate Palmolive Co also receives a moderate score in Dividend, indicating that it may not be a top choice for income investors. Despite this, the company’s products are widely recognized and used globally, showcasing its resilience in the market. With a diverse range of products including toothpaste, shampoos, and pet nutrition, Colgate Palmolive Co is well-positioned to maintain its competitive edge. Investors looking for a company with strong growth potential and market momentum may find Colgate Palmolive Co an attractive option.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma